Literature DB >> 17011329

Predictors of seizure onset in Rett syndrome.

Le Jian1, Lakshmi Nagarajan, Nicholas de Klerk, David Ravine, Carol Bower, Alison Anderson, Sarah Williamson, John Christodoulou, Helen Leonard.   

Abstract

OBJECTIVES: To investigate risk factors for seizure onset in Rett syndrome. STUDY
DESIGN: Information on presence and age at onset of seizures, perinatal and developmental history, and genetic status was abstracted on 275 cases in the Australian Rett Syndrome Database. Cox and Weibull regression were used to investigate and provide a model for predicting the effects of genetic and developmental factors on age at seizure onset.
RESULTS: Seizures were reported in 81% of 275 cases; the median age of onset was 48 months. Not having gained the ability to walk (P = .003) and developmental problems in the first 10 months of age (P = .04) were associated with an almost 2-fold increased risk of seizures. Cases without a detectable MECP2 mutation had a higher risk of seizure onset up to 4 years of age (P < .001) but a lower risk after 4 years (P = .08).
CONCLUSIONS: Seizure onset in Rett syndrome is associated with early developmental factors and with genotype. Information on these factors can be used to predict age at seizure onset after diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17011329     DOI: 10.1016/j.jpeds.2006.06.015

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  38 in total

1.  The phenotype associated with a large deletion on MECP2.

Authors:  Ami Bebbington; Jenny Downs; Alan Percy; Mercé Pineda; Bruria Ben Zeev; Nadia Bahi-Buisson; Helen Leonard
Journal:  Eur J Hum Genet       Date:  2012-04-04       Impact factor: 4.246

Review 2.  Long noncoding RNA and its contribution to autism spectrum disorders.

Authors:  Jie Tang; Yizhen Yu; Wei Yang
Journal:  CNS Neurosci Ther       Date:  2017-06-20       Impact factor: 5.243

Review 3.  Epigenetic mechanisms in stroke and epilepsy.

Authors:  Jee-Yeon Hwang; Kelly A Aromolaran; R Suzanne Zukin
Journal:  Neuropsychopharmacology       Date:  2012-08-15       Impact factor: 7.853

4.  Loss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via α7 receptor in hippocampus.

Authors:  Ying Zhang; Shu-Xia Cao; Peng Sun; Hai-Yang He; Ci-Hang Yang; Xiao-Juan Chen; Chen-Jie Shen; Xiao-Dong Wang; Zhong Chen; Darwin K Berg; Shumin Duan; Xiao-Ming Li
Journal:  Cell Res       Date:  2016-04-22       Impact factor: 25.617

5.  Level of purposeful hand function as a marker of clinical severity in Rett syndrome.

Authors:  Jenny Downs; Ami Bebbington; Peter Jacoby; Anne-Marie Williams; Soumya Ghosh; Walter E Kaufmann; Helen Leonard
Journal:  Dev Med Child Neurol       Date:  2010-03-19       Impact factor: 5.449

6.  The neural circuit basis of Rett syndrome.

Authors:  Darren Goffin; Zhaolan Joe Zhou
Journal:  Front Biol (Beijing)       Date:  2012-10

7.  The relationship between MECP2 mutation type and health status and service use trajectories over time in a Rett syndrome population.

Authors:  Deidra Young; Ami Bebbington; Nick de Klerk; Carol Bower; Lakshmi Nagarajan; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2011-01

8.  MeCP2 Modulates Sex Differences in the Postsynaptic Development of the Valproate Animal Model of Autism.

Authors:  Ki Chan Kim; Chang Soon Choi; Ji-Woon Kim; Seol-Heui Han; Jae Hoon Cheong; Jong Hoon Ryu; Chan Young Shin
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

9.  ΔFosB Regulates Gene Expression and Cognitive Dysfunction in a Mouse Model of Alzheimer's Disease.

Authors:  Brian F Corbett; Jason C You; Xiaohong Zhang; Mark S Pyfer; Umberto Tosi; Daniel M Iascone; Iraklis Petrof; Anupam Hazra; Chia-Hsuan Fu; Gabriel S Stephens; Annie A Ashok; Suzan Aschmies; Lijuan Zhao; Eric J Nestler; Jeannie Chin
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

10.  NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2.

Authors:  Severine Durand; Annarita Patrizi; Kathleen B Quast; Lea Hachigian; Roman Pavlyuk; Alka Saxena; Piero Carninci; Takao K Hensch; Michela Fagiolini
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.